News
ILMN
137.32
-0.98%
-1.36
Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event
Volatility watch - Options trading volume is elevated on Trump Media & Technology (DJT) Key data reports due to arrive this week include updates on Tesla deliveries, Disney board vote, and Solventum spin-off. Fortinet will hold its four-day Accelerate 2024 event in New York.
Seeking Alpha · 18h ago
May 10th Options Now Available For Illumina (ILMN)
NASDAQ · 22h ago
GRAIL Presents New Data On Galleri And Its Methylation Platform At The Annual American Association For Cancer Research Meeting
New Data Will Highlight Use of GRAIL's Targeted Methylation Platform across Early Cancer Detection and Precision Oncology at the American Association for Cancer Research Annual Meeting in San Diego, 2024. Longer-term data Underscore the Potential Value of Galleri for Repeat Screening for Clinically Significant Cancers. GRAil will present new data on the impact of multi-cancer early detection testing in guiding diagnostic evaluation.
Benzinga · 2d ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
NASDAQ · 3d ago
Weekly Report: what happened at ILMN last week (0318-0322)?
Weekly Report · 4d ago
Illumina’s Stock Rating Maintained at Hold Amid Legal Uncertainties and Regulatory Challenges
TipRanks · 03/22 11:17
Why Illumina Stock Zoomed Higher on Thursday
Gene-sequencing specialist Illumina's share price rose over 3% on Thursday. A European Commission advisor criticized the Commission's ruling on an Illumina acquisition. The company's $8 billion deal to purchase cancer detection company Grail was blocked in 2021. The European Commission says the ruling should be annulled.
The Motley Fool · 03/21 22:37
EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser
EU antitrust regulators blocked Illumina's $7.1 billion bid for Grail Inc. An adviser to Europe's top court says the EU exceeded their powers in blocking the deal. The adviser's opinion could impact other merger deals in the future, including one involving Qualcomm Inc.
Benzinga · 03/21 17:56
BUZZ-U.S. STOCKS ON THE MOVE-Advance Auto Parts, Illumina, Reddit
Wall Street's main stock indexes touched record highs on Thursday. The Dow Jones Industrial Average was up 0.77% and the S&P 500 and Nasdaq Composite hit record highs. Chip stocks rallied following Micron Technology's upbeat forecast. Advance Auto Parts, Illumina, Reddit are among the day's top stocks on the NYSE.
Reuters · 03/21 17:48
BUZZ-U.S. STOCKS ON THE MOVE-Advance Auto Parts, Illumina, Toll Brothers
Wall Street's main stock indexes climbed to record highs on Thursday. The Dow Jones Industrial Average was up 0.82% at 39,834.62. Chip stocks rallied following Micron Technology's upbeat forecast. Investors took comfort in the Federal Reserve sticking to its three-rate-cut view for this year.
Reuters · 03/21 15:53
Stock Indexes Rally to Record Highs on a Resilient US Economy
S&P 500, Dow Jones Industrials, and Nasdaq 100 post new all-time highs on Thursday. Stocks rallied on the outlook for Fed rate cuts later this year. The Euro Stoxx 50 climbs to a 23-year high and closes up +1.04%. Overseas stock markets on Thursday settled mixed. June T-notes turn lower on stronger-than-expected US economic reports, hawkish factors.
Barchart · 03/21 15:32
Nasdaq 100 Movers: PDD, MU
NASDAQ · 03/21 14:22
S&P 500 Movers: ACN, MU
NASDAQ · 03/21 14:20
BUZZ-Illumina gains as EU court adviser backs appeal against Grail-deal review
Shares of U.S. Life sciences firm Illumina up 6.4% at $141.75. EU court adviser backs appeal against Grail-deal review. Co wins backing of an adviser to Europe's top court. EU antitrust regulators do have the power to scrutinise its $7.1 billion bid for Grail.
Reuters · 03/21 13:42
Illumina gains as adviser to EU top court backs appeal over Grail deal
Healthcare M&A Illumina gains as adviser to EU top court backs appeal over Grail deal. U.S. Company acquired cancer test developer Grail in $8B deal. EU's top court says regulators overstepped their powers in opposing Illumina's deal.
Seeking Alpha · 03/21 13:22
Illumina Shares Higher After Europe's Top Court Said EU Antitrust Regulators Exceeded Powers By Blocking Bid For Grail
Benzinga · 03/21 11:54
Stock Indexes Post Record Highs on Rate Cut and Soft-Landing Optimism
S&P 500, Dow Jones Industrials, and Nasdaq 100 post new all-time highs this morning. Stocks are climbing on the outlook for Fed rate cuts later this year. Stronger than expected US economic reports bolster outlook for an economic soft landing. European stock markets today are mixed. T-notes turn lower on hawkish factors for Fed policy.
Barchart · 03/21 10:29
UPDATE 1-Boost for Illumina as court adviser rejects EU merger powers
U.S. Gene sequencing company Illumina wins backing of adviser to Europe's top court. EU antitrust regulators blocked Illumina's $7.1 billion bid for Grail GRAL.O block it. European Commission asserted a rarely used power to assess the deal. Court adviser rejects EU merger powers.
Reuters · 03/21 09:44
Stock Indexes Climb to Record Highs on Expectations for Fed Rate Cuts
S&P 500, Dow Jones Industrials, and Nasdaq 100 post new all-time highs this morning. Stocks are climbing on the outlook for Fed rate cuts later this year. The FOMC maintained its projections for 75 bp of interest rate cuts this year and raised 2024 US GDP forecast. T-notes fall back from their best levels on stronger-than-expected US weekly initial unemployment claims and Philadelphia Fed reports. Overseas stock markets today are mixed.
Barchart · 03/21 09:19
Illumina Cut to Mixed From Positive by OTR Global
Dow Jones · 03/20 16:05
More
Webull provides a variety of real-time ILMN stock news. You can receive the latest news about Illumina Inc through multiple platforms. This information may help you make smarter investment decisions.
About ILMN
Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.